nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2E1—Dacarbazine—muscle cancer	0.154	0.393	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—muscle cancer	0.0754	0.192	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—muscle cancer	0.0507	0.129	CbGbCtD
Sevoflurane—ALB—Methotrexate—muscle cancer	0.0482	0.123	CbGbCtD
Sevoflurane—CYP3A4—Vincristine—muscle cancer	0.0249	0.0636	CbGbCtD
Sevoflurane—CYP3A4—Etoposide—muscle cancer	0.0228	0.0583	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—muscle cancer	0.0156	0.0398	CbGbCtD
Sevoflurane—KCNK10—renal system—muscle cancer	0.0103	0.0347	CbGeAlD
Sevoflurane—KCNK3—renal system—muscle cancer	0.00926	0.0314	CbGeAlD
Sevoflurane—Obstructive airways disorder—Methotrexate—muscle cancer	0.00882	0.0282	CcSEcCtD
Sevoflurane—Electrocardiogram ST segment depression—Doxorubicin—muscle cancer	0.00764	0.0244	CcSEcCtD
Sevoflurane—KCNK2—tendon—muscle cancer	0.00748	0.0253	CbGeAlD
Sevoflurane—KCNK2—vagina—muscle cancer	0.00694	0.0235	CbGeAlD
Sevoflurane—KCNK10—head—muscle cancer	0.00686	0.0232	CbGeAlD
Sevoflurane—KCNK9—head—muscle cancer	0.00682	0.0231	CbGeAlD
Sevoflurane—ND1—smooth muscle tissue—muscle cancer	0.00667	0.0226	CbGeAlD
Sevoflurane—ND1—renal system—muscle cancer	0.00642	0.0217	CbGeAlD
Sevoflurane—KCNK2—testis—muscle cancer	0.0062	0.021	CbGeAlD
Sevoflurane—KCNK3—head—muscle cancer	0.0062	0.021	CbGeAlD
Sevoflurane—KCNA1—tendon—muscle cancer	0.00569	0.0193	CbGeAlD
Sevoflurane—GABRQ—head—muscle cancer	0.00552	0.0187	CbGeAlD
Sevoflurane—ATP5D—smooth muscle tissue—muscle cancer	0.00537	0.0182	CbGeAlD
Sevoflurane—ATP2C1—smooth muscle tissue—muscle cancer	0.0053	0.018	CbGeAlD
Sevoflurane—ATP5D—renal system—muscle cancer	0.00517	0.0175	CbGeAlD
Sevoflurane—ATP2C1—renal system—muscle cancer	0.00511	0.0173	CbGeAlD
Sevoflurane—GRIA1—head—muscle cancer	0.00499	0.0169	CbGeAlD
Sevoflurane—KCNA1—head—muscle cancer	0.00487	0.0165	CbGeAlD
Sevoflurane—ND1—bone marrow—muscle cancer	0.00485	0.0164	CbGeAlD
Sevoflurane—GABRG3—head—muscle cancer	0.00484	0.0164	CbGeAlD
Sevoflurane—GRIA1—testis—muscle cancer	0.00482	0.0163	CbGeAlD
Sevoflurane—GABRG3—testis—muscle cancer	0.00467	0.0158	CbGeAlD
Sevoflurane—Supraventricular extrasystoles—Doxorubicin—muscle cancer	0.00466	0.0149	CcSEcCtD
Sevoflurane—ATP5D—cardiac atrium—muscle cancer	0.00463	0.0157	CbGeAlD
Sevoflurane—ATP2C1—cardiac atrium—muscle cancer	0.00457	0.0155	CbGeAlD
Sevoflurane—Laryngospasm—Etoposide—muscle cancer	0.00448	0.0143	CcSEcCtD
Sevoflurane—ND1—head—muscle cancer	0.00429	0.0145	CbGeAlD
Sevoflurane—Respiratory failure—Vincristine—muscle cancer	0.0042	0.0134	CcSEcCtD
Sevoflurane—ND1—testis—muscle cancer	0.00415	0.014	CbGeAlD
Sevoflurane—GABRB1—vagina—muscle cancer	0.00405	0.0137	CbGeAlD
Sevoflurane—ATP5D—tendon—muscle cancer	0.00404	0.0137	CbGeAlD
Sevoflurane—GABRD—head—muscle cancer	0.004	0.0136	CbGeAlD
Sevoflurane—ATP2C1—tendon—muscle cancer	0.00399	0.0135	CbGeAlD
Sevoflurane—Apnoea—Etoposide—muscle cancer	0.00395	0.0126	CcSEcCtD
Sevoflurane—GABRA4—tendon—muscle cancer	0.00394	0.0133	CbGeAlD
Sevoflurane—ATP5D—bone marrow—muscle cancer	0.00391	0.0132	CbGeAlD
Sevoflurane—GABRD—testis—muscle cancer	0.00387	0.0131	CbGeAlD
Sevoflurane—ATP2C1—bone marrow—muscle cancer	0.00386	0.0131	CbGeAlD
Sevoflurane—GABRG1—head—muscle cancer	0.00386	0.0131	CbGeAlD
Sevoflurane—GABRA6—head—muscle cancer	0.00383	0.013	CbGeAlD
Sevoflurane—Chest discomfort—Etoposide—muscle cancer	0.00378	0.0121	CcSEcCtD
Sevoflurane—ATP5D—vagina—muscle cancer	0.00375	0.0127	CbGeAlD
Sevoflurane—GABRB1—head—muscle cancer	0.00374	0.0127	CbGeAlD
Sevoflurane—Hepatic failure—Dactinomycin—muscle cancer	0.00373	0.0119	CcSEcCtD
Sevoflurane—GABRA5—head—muscle cancer	0.00372	0.0126	CbGeAlD
Sevoflurane—ATP2C1—vagina—muscle cancer	0.0037	0.0125	CbGeAlD
Sevoflurane—GABRP—vagina—muscle cancer	0.00363	0.0123	CbGeAlD
Sevoflurane—GABRA5—testis—muscle cancer	0.00359	0.0122	CbGeAlD
Sevoflurane—GABRA3—head—muscle cancer	0.00346	0.0117	CbGeAlD
Sevoflurane—ATP5D—head—muscle cancer	0.00346	0.0117	CbGeAlD
Sevoflurane—GABRE—cardiac atrium—muscle cancer	0.00342	0.0116	CbGeAlD
Sevoflurane—ATP2C1—head—muscle cancer	0.00342	0.0116	CbGeAlD
Sevoflurane—GABRA4—head—muscle cancer	0.00337	0.0114	CbGeAlD
Sevoflurane—GABRP—head—muscle cancer	0.00335	0.0113	CbGeAlD
Sevoflurane—GABRA3—testis—muscle cancer	0.00334	0.0113	CbGeAlD
Sevoflurane—ATP5D—testis—muscle cancer	0.00334	0.0113	CbGeAlD
Sevoflurane—Hepatic failure—Vincristine—muscle cancer	0.00334	0.0107	CcSEcCtD
Sevoflurane—ATP2C1—testis—muscle cancer	0.0033	0.0112	CbGeAlD
Sevoflurane—CYP2A6—vagina—muscle cancer	0.00316	0.0107	CbGeAlD
Sevoflurane—Hypoxia—Methotrexate—muscle cancer	0.00315	0.0101	CcSEcCtD
Sevoflurane—Urine abnormality—Doxorubicin—muscle cancer	0.00313	0.01	CcSEcCtD
Sevoflurane—Liver function test abnormal—Dactinomycin—muscle cancer	0.0031	0.00989	CcSEcCtD
Sevoflurane—Hypothermia—Doxorubicin—muscle cancer	0.00309	0.00989	CcSEcCtD
Sevoflurane—Body temperature decreased—Doxorubicin—muscle cancer	0.00309	0.00989	CcSEcCtD
Sevoflurane—Hypophosphataemia—Doxorubicin—muscle cancer	0.00298	0.00954	CcSEcCtD
Sevoflurane—GABRE—tendon—muscle cancer	0.00298	0.0101	CbGeAlD
Sevoflurane—Urine analysis abnormal—Doxorubicin—muscle cancer	0.00295	0.00942	CcSEcCtD
Sevoflurane—Cardiac arrest—Vincristine—muscle cancer	0.00285	0.0091	CcSEcCtD
Sevoflurane—Urinary retention—Vincristine—muscle cancer	0.00285	0.0091	CcSEcCtD
Sevoflurane—GABRB2—head—muscle cancer	0.00282	0.00956	CbGeAlD
Sevoflurane—GABRG2—head—muscle cancer	0.00282	0.00956	CbGeAlD
Sevoflurane—GABRA2—vagina—muscle cancer	0.00279	0.00945	CbGeAlD
Sevoflurane—GABRE—vagina—muscle cancer	0.00277	0.00937	CbGeAlD
Sevoflurane—GABRB2—testis—muscle cancer	0.00273	0.00923	CbGeAlD
Sevoflurane—GABRA2—head—muscle cancer	0.00258	0.00873	CbGeAlD
Sevoflurane—GABRE—head—muscle cancer	0.00256	0.00866	CbGeAlD
Sevoflurane—Hyperventilation—Doxorubicin—muscle cancer	0.00252	0.00805	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Etoposide—muscle cancer	0.00251	0.00801	CcSEcCtD
Sevoflurane—GABRA1—head—muscle cancer	0.00249	0.00844	CbGeAlD
Sevoflurane—GABRE—testis—muscle cancer	0.00247	0.00836	CbGeAlD
Sevoflurane—Dysuria—Vincristine—muscle cancer	0.00242	0.00774	CcSEcCtD
Sevoflurane—Apnoea—Methotrexate—muscle cancer	0.00236	0.00755	CcSEcCtD
Sevoflurane—Albuminuria—Doxorubicin—muscle cancer	0.00232	0.00742	CcSEcCtD
Sevoflurane—Hepatitis—Dactinomycin—muscle cancer	0.00232	0.00741	CcSEcCtD
Sevoflurane—Cardiac arrest—Etoposide—muscle cancer	0.00231	0.00738	CcSEcCtD
Sevoflurane—Pharyngitis—Dactinomycin—muscle cancer	0.0023	0.00736	CcSEcCtD
Sevoflurane—ALB—testis—muscle cancer	0.00225	0.00762	CbGeAlD
Sevoflurane—Amblyopia—Doxorubicin—muscle cancer	0.00225	0.00718	CcSEcCtD
Sevoflurane—Bone disorder—Methotrexate—muscle cancer	0.00222	0.00709	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.0022	0.00704	CcSEcCtD
Sevoflurane—CYP2B6—renal system—muscle cancer	0.0022	0.00744	CbGeAlD
Sevoflurane—Oliguria—Methotrexate—muscle cancer	0.00217	0.00694	CcSEcCtD
Sevoflurane—GABRB3—head—muscle cancer	0.00217	0.00734	CbGeAlD
Sevoflurane—Glycosuria—Doxorubicin—muscle cancer	0.00214	0.00684	CcSEcCtD
Sevoflurane—GABRB3—testis—muscle cancer	0.00209	0.00709	CbGeAlD
Sevoflurane—Chills—Dactinomycin—muscle cancer	0.00208	0.00665	CcSEcCtD
Sevoflurane—Bronchospasm—Etoposide—muscle cancer	0.00206	0.00659	CcSEcCtD
Sevoflurane—CYP2E1—renal system—muscle cancer	0.00206	0.00698	CbGeAlD
Sevoflurane—Urinary tract disorder—Vincristine—muscle cancer	0.00205	0.00654	CcSEcCtD
Sevoflurane—Respiratory failure—Methotrexate—muscle cancer	0.00204	0.00652	CcSEcCtD
Sevoflurane—Urethral disorder—Vincristine—muscle cancer	0.00203	0.00649	CcSEcCtD
Sevoflurane—Cardiac disorder—Vincristine—muscle cancer	0.00192	0.00615	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00192	0.00614	CcSEcCtD
Sevoflurane—Bone disorder—Doxorubicin—muscle cancer	0.00192	0.00614	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.00191	0.00609	CcSEcCtD
Sevoflurane—Cough increased—Doxorubicin—muscle cancer	0.00189	0.00605	CcSEcCtD
Sevoflurane—Oliguria—Doxorubicin—muscle cancer	0.00188	0.00601	CcSEcCtD
Sevoflurane—Angiopathy—Vincristine—muscle cancer	0.00188	0.00601	CcSEcCtD
Sevoflurane—Mediastinal disorder—Vincristine—muscle cancer	0.00187	0.00597	CcSEcCtD
Sevoflurane—Renal failure—Etoposide—muscle cancer	0.00184	0.00588	CcSEcCtD
Sevoflurane—Jaundice—Etoposide—muscle cancer	0.00182	0.00583	CcSEcCtD
Sevoflurane—Mental disorder—Vincristine—muscle cancer	0.00182	0.0058	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Etoposide—muscle cancer	0.00177	0.00565	CcSEcCtD
Sevoflurane—Hiccups—Doxorubicin—muscle cancer	0.00173	0.00554	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00173	0.00554	CcSEcCtD
Sevoflurane—Dermatitis contact—Doxorubicin—muscle cancer	0.00171	0.00548	CcSEcCtD
Sevoflurane—Hyperkalaemia—Doxorubicin—muscle cancer	0.0017	0.00544	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00168	0.00538	CcSEcCtD
Sevoflurane—Urinary tract disorder—Etoposide—muscle cancer	0.00166	0.0053	CcSEcCtD
Sevoflurane—Agitation—Vincristine—muscle cancer	0.00166	0.0053	CcSEcCtD
Sevoflurane—CYP3A4—renal system—muscle cancer	0.00166	0.00561	CbGeAlD
Sevoflurane—Oedema—Dactinomycin—muscle cancer	0.00165	0.00527	CcSEcCtD
Sevoflurane—Urethral disorder—Etoposide—muscle cancer	0.00165	0.00526	CcSEcCtD
Sevoflurane—Hepatic failure—Methotrexate—muscle cancer	0.00162	0.00517	CcSEcCtD
Sevoflurane—Thrombocytopenia—Dactinomycin—muscle cancer	0.00161	0.00516	CcSEcCtD
Sevoflurane—CYP2E1—tendon—muscle cancer	0.00161	0.00545	CbGeAlD
Sevoflurane—CYP2B6—vagina—muscle cancer	0.00159	0.00539	CbGeAlD
Sevoflurane—Renal failure acute—Methotrexate—muscle cancer	0.00158	0.00503	CcSEcCtD
Sevoflurane—Convulsion—Vincristine—muscle cancer	0.00156	0.005	CcSEcCtD
Sevoflurane—Cardiac disorder—Etoposide—muscle cancer	0.00156	0.00498	CcSEcCtD
Sevoflurane—Hypertension—Vincristine—muscle cancer	0.00156	0.00498	CcSEcCtD
Sevoflurane—Angiopathy—Etoposide—muscle cancer	0.00152	0.00487	CcSEcCtD
Sevoflurane—Hypertonia—Doxorubicin—muscle cancer	0.00152	0.00486	CcSEcCtD
Sevoflurane—Immune system disorder—Etoposide—muscle cancer	0.00152	0.00485	CcSEcCtD
Sevoflurane—Mediastinal disorder—Etoposide—muscle cancer	0.00151	0.00484	CcSEcCtD
Sevoflurane—Chills—Etoposide—muscle cancer	0.00151	0.00481	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Methotrexate—muscle cancer	0.0015	0.0048	CcSEcCtD
Sevoflurane—Anaphylactic shock—Vincristine—muscle cancer	0.00147	0.00471	CcSEcCtD
Sevoflurane—Oedema—Vincristine—muscle cancer	0.00147	0.00471	CcSEcCtD
Sevoflurane—CYP2B6—head—muscle cancer	0.00147	0.00497	CbGeAlD
Sevoflurane—Nervous system disorder—Vincristine—muscle cancer	0.00144	0.00461	CcSEcCtD
Sevoflurane—Thrombocytopenia—Vincristine—muscle cancer	0.00144	0.00461	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00144	0.0046	CcSEcCtD
Sevoflurane—Dysgeusia—Etoposide—muscle cancer	0.00143	0.00457	CcSEcCtD
Sevoflurane—CYP2B6—testis—muscle cancer	0.00142	0.00481	CbGeAlD
Sevoflurane—Pain—Dactinomycin—muscle cancer	0.00141	0.0045	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—muscle cancer	0.0014	0.00448	CcSEcCtD
Sevoflurane—CYP2E1—head—muscle cancer	0.00138	0.00467	CbGeAlD
Sevoflurane—Hypotension—Vincristine—muscle cancer	0.00138	0.0044	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—muscle cancer	0.00136	0.00436	CcSEcCtD
Sevoflurane—Feeling abnormal—Dactinomycin—muscle cancer	0.00136	0.00434	CcSEcCtD
Sevoflurane—Liver function test abnormal—Methotrexate—muscle cancer	0.00134	0.00429	CcSEcCtD
Sevoflurane—Insomnia—Vincristine—muscle cancer	0.00133	0.00426	CcSEcCtD
Sevoflurane—CYP2E1—testis—muscle cancer	0.00133	0.00451	CbGeAlD
Sevoflurane—Body temperature increased—Dactinomycin—muscle cancer	0.0013	0.00416	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.0013	0.00416	CcSEcCtD
Sevoflurane—Loss of consciousness—Etoposide—muscle cancer	0.00129	0.00411	CcSEcCtD
Sevoflurane—Cough—Etoposide—muscle cancer	0.00128	0.00408	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Vincristine—muscle cancer	0.00127	0.00406	CcSEcCtD
Sevoflurane—Convulsion—Etoposide—muscle cancer	0.00127	0.00405	CcSEcCtD
Sevoflurane—Hypertension—Etoposide—muscle cancer	0.00126	0.00403	CcSEcCtD
Sevoflurane—Pain—Vincristine—muscle cancer	0.00126	0.00402	CcSEcCtD
Sevoflurane—Chest pain—Etoposide—muscle cancer	0.00124	0.00398	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00124	0.00395	CcSEcCtD
Sevoflurane—Pancreatitis—Methotrexate—muscle cancer	0.00123	0.00394	CcSEcCtD
Sevoflurane—Hypersensitivity—Dactinomycin—muscle cancer	0.00121	0.00388	CcSEcCtD
Sevoflurane—Confusional state—Etoposide—muscle cancer	0.0012	0.00384	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—muscle cancer	0.0012	0.00383	CcSEcCtD
Sevoflurane—Anaphylactic shock—Etoposide—muscle cancer	0.00119	0.00381	CcSEcCtD
Sevoflurane—Asthenia—Dactinomycin—muscle cancer	0.00118	0.00378	CcSEcCtD
Sevoflurane—Dysuria—Methotrexate—muscle cancer	0.00118	0.00375	CcSEcCtD
Sevoflurane—Thrombocytopenia—Etoposide—muscle cancer	0.00117	0.00373	CcSEcCtD
Sevoflurane—Tachycardia—Etoposide—muscle cancer	0.00116	0.00372	CcSEcCtD
Sevoflurane—Body temperature increased—Vincristine—muscle cancer	0.00116	0.00372	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—muscle cancer	0.00116	0.00371	CcSEcCtD
Sevoflurane—Skin disorder—Etoposide—muscle cancer	0.00116	0.0037	CcSEcCtD
Sevoflurane—Hypotension—Etoposide—muscle cancer	0.00112	0.00356	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—muscle cancer	0.0011	0.00352	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—muscle cancer	0.00109	0.00348	CcSEcCtD
Sevoflurane—Hypersensitivity—Vincristine—muscle cancer	0.00109	0.00347	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—muscle cancer	0.00107	0.00341	CcSEcCtD
Sevoflurane—Dyspnoea—Etoposide—muscle cancer	0.00106	0.0034	CcSEcCtD
Sevoflurane—Somnolence—Etoposide—muscle cancer	0.00106	0.00339	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—muscle cancer	0.00106	0.00339	CcSEcCtD
Sevoflurane—Asthenia—Vincristine—muscle cancer	0.00106	0.00338	CcSEcCtD
Sevoflurane—Vomiting—Dactinomycin—muscle cancer	0.00105	0.00335	CcSEcCtD
Sevoflurane—Rash—Dactinomycin—muscle cancer	0.00104	0.00332	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Etoposide—muscle cancer	0.00103	0.00329	CcSEcCtD
Sevoflurane—Pain—Etoposide—muscle cancer	0.00102	0.00326	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—muscle cancer	0.00102	0.00325	CcSEcCtD
Sevoflurane—Haemoglobin—Methotrexate—muscle cancer	0.00101	0.00323	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—muscle cancer	0.00101	0.00321	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—muscle cancer	0.00101	0.00321	CcSEcCtD
Sevoflurane—Pharyngitis—Methotrexate—muscle cancer	0.000999	0.00319	CcSEcCtD
Sevoflurane—Urinary tract disorder—Methotrexate—muscle cancer	0.000994	0.00317	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—muscle cancer	0.000986	0.00315	CcSEcCtD
Sevoflurane—Feeling abnormal—Etoposide—muscle cancer	0.000983	0.00314	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—muscle cancer	0.000982	0.00314	CcSEcCtD
Sevoflurane—Nausea—Dactinomycin—muscle cancer	0.000979	0.00313	CcSEcCtD
Sevoflurane—Dizziness—Vincristine—muscle cancer	0.000974	0.00311	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—muscle cancer	0.000954	0.00305	CcSEcCtD
Sevoflurane—Urticaria—Etoposide—muscle cancer	0.000948	0.00303	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—muscle cancer	0.000946	0.00302	CcSEcCtD
Sevoflurane—Body temperature increased—Etoposide—muscle cancer	0.000943	0.00301	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—muscle cancer	0.000943	0.00301	CcSEcCtD
Sevoflurane—Vomiting—Vincristine—muscle cancer	0.000937	0.00299	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—muscle cancer	0.000934	0.00298	CcSEcCtD
Sevoflurane—Rash—Vincristine—muscle cancer	0.000929	0.00297	CcSEcCtD
Sevoflurane—Dermatitis—Vincristine—muscle cancer	0.000928	0.00296	CcSEcCtD
Sevoflurane—Headache—Vincristine—muscle cancer	0.000923	0.00295	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000918	0.00293	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—muscle cancer	0.000913	0.00292	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—muscle cancer	0.000909	0.0029	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—muscle cancer	0.000907	0.0029	CcSEcCtD
Sevoflurane—Chills—Methotrexate—muscle cancer	0.000903	0.00288	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—muscle cancer	0.000887	0.00283	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—muscle cancer	0.000881	0.00282	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—muscle cancer	0.000879	0.00281	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—muscle cancer	0.000876	0.0028	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—muscle cancer	0.000876	0.0028	CcSEcCtD
Sevoflurane—Nausea—Vincristine—muscle cancer	0.000875	0.0028	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—muscle cancer	0.000871	0.00278	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—muscle cancer	0.000871	0.00278	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—muscle cancer	0.000865	0.00276	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—muscle cancer	0.00086	0.00275	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—muscle cancer	0.000858	0.00274	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—muscle cancer	0.000856	0.00274	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—muscle cancer	0.000854	0.00273	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—muscle cancer	0.000844	0.0027	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—muscle cancer	0.000809	0.00258	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—muscle cancer	0.00079	0.00252	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—muscle cancer	0.000789	0.00252	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—muscle cancer	0.000787	0.00251	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—muscle cancer	0.000785	0.00251	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—muscle cancer	0.000782	0.0025	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—muscle cancer	0.000778	0.00249	CcSEcCtD
Sevoflurane—Cough—Methotrexate—muscle cancer	0.000764	0.00244	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—muscle cancer	0.000763	0.00244	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—muscle cancer	0.000759	0.00242	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—muscle cancer	0.000759	0.00242	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—muscle cancer	0.000758	0.00242	CcSEcCtD
Sevoflurane—Rash—Etoposide—muscle cancer	0.000752	0.0024	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—muscle cancer	0.000752	0.0024	CcSEcCtD
Sevoflurane—Headache—Etoposide—muscle cancer	0.000748	0.00239	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—muscle cancer	0.000746	0.00238	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—muscle cancer	0.000744	0.00238	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—muscle cancer	0.000743	0.00237	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00074	0.00237	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—muscle cancer	0.000737	0.00235	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—muscle cancer	0.000721	0.0023	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—muscle cancer	0.000715	0.00228	CcSEcCtD
Sevoflurane—Nausea—Etoposide—muscle cancer	0.000709	0.00226	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—muscle cancer	0.000701	0.00224	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—muscle cancer	0.0007	0.00224	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—muscle cancer	0.000697	0.00223	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—muscle cancer	0.000694	0.00222	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—muscle cancer	0.00068	0.00217	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—muscle cancer	0.000668	0.00213	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—muscle cancer	0.000667	0.00213	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—muscle cancer	0.000662	0.00211	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—muscle cancer	0.000657	0.0021	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—muscle cancer	0.000655	0.00209	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—muscle cancer	0.000646	0.00207	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—muscle cancer	0.000646	0.00206	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000641	0.00205	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—muscle cancer	0.000637	0.00204	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—muscle cancer	0.000635	0.00203	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—muscle cancer	0.000631	0.00202	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—muscle cancer	0.000624	0.00199	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—muscle cancer	0.000619	0.00198	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—muscle cancer	0.000619	0.00198	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000617	0.00197	CcSEcCtD
Sevoflurane—Pain—Methotrexate—muscle cancer	0.000611	0.00195	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—muscle cancer	0.000609	0.00195	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—muscle cancer	0.000607	0.00194	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—muscle cancer	0.000606	0.00194	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—muscle cancer	0.000604	0.00193	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—muscle cancer	0.000601	0.00192	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—muscle cancer	0.000589	0.00188	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—muscle cancer	0.000578	0.00185	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—muscle cancer	0.000568	0.00181	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—muscle cancer	0.000565	0.00181	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—muscle cancer	0.00056	0.00179	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—muscle cancer	0.000552	0.00176	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—muscle cancer	0.00055	0.00176	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000534	0.00171	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—muscle cancer	0.000529	0.00169	CcSEcCtD
Sevoflurane—Hypersensitivity—Methotrexate—muscle cancer	0.000527	0.00168	CcSEcCtD
Sevoflurane—Asthenia—Methotrexate—muscle cancer	0.000513	0.00164	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—muscle cancer	0.00051	0.00163	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—muscle cancer	0.000506	0.00162	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—muscle cancer	0.000492	0.00157	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—muscle cancer	0.000489	0.00156	CcSEcCtD
Sevoflurane—Dizziness—Methotrexate—muscle cancer	0.000473	0.00151	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—muscle cancer	0.000456	0.00146	CcSEcCtD
Sevoflurane—Vomiting—Methotrexate—muscle cancer	0.000454	0.00145	CcSEcCtD
Sevoflurane—Rash—Methotrexate—muscle cancer	0.000451	0.00144	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—muscle cancer	0.00045	0.00144	CcSEcCtD
Sevoflurane—Headache—Methotrexate—muscle cancer	0.000448	0.00143	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—muscle cancer	0.000444	0.00142	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—muscle cancer	0.000438	0.0014	CcSEcCtD
Sevoflurane—Nausea—Methotrexate—muscle cancer	0.000425	0.00136	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—muscle cancer	0.000409	0.00131	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—muscle cancer	0.000394	0.00126	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—muscle cancer	0.00039	0.00125	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—muscle cancer	0.00039	0.00125	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—muscle cancer	0.000388	0.00124	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—muscle cancer	0.000368	0.00117	CcSEcCtD
